Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts
Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts
專家展望：4位分析師眼中的Beam Therapeutics
In the last three months, 4 analysts have published ratings on Beam Therapeutics (NASDAQ:BEAM), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有4位分析師公佈了對Beam Therapeutics（納斯達克股票代碼：BEAM）的評級，提供了從看漲到看跌的不同視角。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $43.5, along with a high estimate of $57.00 and a low estimate of $35.00. This upward trend is apparent, with the current average reflecting a 43.42% increase from the previous average price target of $30.33.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲43.5美元，最高估計爲57.00美元，低估值爲35.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的30.33美元的平均目標股價上漲了43.42％。
Understanding Analyst Ratings: A Comprehensive Breakdown...
了解分析師評...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。